• Tranzyme Pharma Inc., of Research Triangle Park, N.C., said it received an additional $9.3 million in term loan proceeds through an amendment and restatement of its existing debt financing facility with Oxford Finance LLC and Horizon Technology Finance Corp. The firm will use a portion of the new proceeds to pay off part of its existing debt, and the financing is expected to extend its cash runway into the fourth quarter of 2013.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter